These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 23125179

  • 1. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F, Hou YQ, Song Y, Yuan ZJ.
    Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
    [Abstract] [Full Text] [Related]

  • 2. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
    Jiao JW, Wen F.
    Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580
    [Abstract] [Full Text] [Related]

  • 3. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.
    Huang C, Xu D, Xia Q, Wang P, Rong C, Su Y.
    J Pharm Pharmacol; 2012 Dec; 64(12):1741-50. PubMed ID: 23146037
    [Abstract] [Full Text] [Related]

  • 4. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
    Shi LX, Ma R, Lu R, Xu Q, Zhu ZF, Wang L, Zhou CL, Li XL, Zhang HL, Yao Z.
    Cancer Lett; 2008 Sep 28; 269(1):101-10. PubMed ID: 18538471
    [Abstract] [Full Text] [Related]

  • 5. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z, Ma T, Huang C, Zhang L, Lv X, Xu T, Hu T, Li J.
    Cell Signal; 2013 Dec 28; 25(12):2693-701. PubMed ID: 24018051
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Expression of ERK5 in multidrug-resistant hepatocellular carcinoma cell line].
    Yan F, Wang XM, Pan C.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar 28; 29(3):483-6. PubMed ID: 19304531
    [Abstract] [Full Text] [Related]

  • 13. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
    Gu W, Zhang YN, Li B, Han J, Cheng BB, Ling CQ.
    Zhong Xi Yi Jie He Xue Bao; 2006 May 28; 4(3):265-70. PubMed ID: 16696913
    [Abstract] [Full Text] [Related]

  • 14. Reversing resistance of multidrug-resistant hepatic carcinoma cells with parthenolide.
    Liu D, Liu Y, Liu M, Ran L, Li Y.
    Future Oncol; 2013 Apr 28; 9(4):595-604. PubMed ID: 23560381
    [Abstract] [Full Text] [Related]

  • 15. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Fujishima H, Nakano S, Masumoto N, Esaki T, Tatsumoto T, Kondo T, Niho Y.
    Oncol Res; 1997 Apr 28; 9(4):167-72. PubMed ID: 9268987
    [Abstract] [Full Text] [Related]

  • 16. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
    Gu W, Fang FF, Li B, Cheng BB, Ling CQ.
    Asian Pac J Cancer Prev; 2012 Apr 28; 13(9):4807-14. PubMed ID: 23167424
    [Abstract] [Full Text] [Related]

  • 17. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms].
    Gai XD, Li GL, Huang JZ, Xue HJ, Wang D.
    Ai Zheng; 2006 Aug 28; 25(8):954-9. PubMed ID: 16965674
    [Abstract] [Full Text] [Related]

  • 18. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K.
    Cancer Invest; 2008 May 28; 26(4):344-51. PubMed ID: 18443954
    [Abstract] [Full Text] [Related]

  • 19. The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression.
    Zhou S, Ye W, Duan X, Zhang M, Wang J.
    Dig Dis Sci; 2013 Jun 28; 58(6):1615-26. PubMed ID: 23314856
    [Abstract] [Full Text] [Related]

  • 20. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway.
    Jiao J, Hong S, Zhang J, Ma L, Sun Y, Zhang D, Shen B, Zhu C.
    Cancer Lett; 2012 Jul 01; 320(1):96-103. PubMed ID: 22313545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.